Elevated PARP9 expression is associated with poor prognosis in glioblastoma (37), indicating its role in central nervous system diseases, where excessive DNA damage response may contribute to neuronal apoptosis following a stroke. This evidence concerns the gene PARP9 and central nervous system disorder.